MedMen Enterprises Inc.
MMNFQ
$0.00
$0.000.00%
OTC PK
03/25/2023 | 12/24/2022 | 09/24/2022 | 06/25/2022 | 03/26/2022 | |
---|---|---|---|---|---|
Revenue | 120.13M | 128.16M | 134.12M | 140.81M | 145.52M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 120.13M | 128.16M | 134.12M | 140.81M | 145.52M |
Cost of Revenue | 59.82M | 63.79M | 66.92M | 71.08M | 75.00M |
Gross Profit | 60.31M | 64.37M | 67.20M | 69.73M | 70.52M |
SG&A Expenses | 76.99M | 86.39M | 99.80M | 114.75M | 124.33M |
Depreciation & Amortization | 16.95M | 19.28M | 22.18M | 24.06M | 22.82M |
Other Operating Expenses | -2.63M | -8.20M | -6.47M | -4.96M | -2.74M |
Total Operating Expenses | 151.14M | 161.26M | 182.44M | 204.94M | 219.41M |
Operating Income | -31.00M | -33.10M | -48.32M | -64.12M | -73.89M |
Income Before Tax | -176.39M | -159.29M | -161.61M | -170.02M | -92.37M |
Income Tax Expenses | -23.56M | -18.20M | -27.39M | -9.90M | 11.28M |
Earnings from Continuing Operations | -152.83 | -141.09 | -134.22 | -160.13 | -103.65 |
Earnings from Discontinued Operations | 4.56M | -2.13M | -12.02M | -50.77M | -53.52M |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 13.65M | 10.34M | 10.54M | 15.71M | 14.25M |
Net Income | -134.62M | -132.88M | -135.70M | -195.19M | -142.92M |
EBIT | -31.00M | -33.10M | -48.32M | -64.12M | -73.89M |
EBITDA | -12.88M | -12.70M | -21.25M | -34.77M | -44.97M |
EPS Basic | -0.10 | -0.11 | -0.11 | -0.17 | -0.16 |
Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.05 |
EPS Diluted | -0.10 | -0.11 | -0.12 | -0.18 | -0.16 |
Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.05 |
Average Basic Shares Outstanding | 5.21B | 5.08B | 4.97B | 4.61B | 4.02B |
Average Diluted Shares Outstanding | 5.21B | 5.08B | 4.97B | 4.61B | 4.02B |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |